Research Topics
Species | M CicardiSummaryAffiliation: University of Milan Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologistMarco Cicardi
Dipartimento di Scienze Mediche L Sacco, Universita di Milano, Ospedale L Sacco Milano, Milan, Italy
Acta Haematol 127:208-20. 2012....
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working GroupM Cicardi
Dipartimento di Scienze Cliniche Luigi Sacco, Universita di Milano, Ospedale L Sacco, Milano, Italy
Allergy 67:147-57. 2012..Here, we report the topics discussed during the meeting and evidence-based consensus about management approaches for HAE in adult/adolescent patients...
HAE international home therapy consensus documentHilary J Longhurst
Department of Immunology, Barts and The London NHS Trust, London, UK
Allergy Asthma Clin Immunol 6:22. 2010..It represents the opinion of the authors who have a wide range of expert experience in the management of HAE...
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaTom Bowen
Departments of Medicine and Paediatrics, University of Calgary, Calgary, Alberta, Canada
Allergy Asthma Clin Immunol 6:24. 2010....
Acquired angioedemaMarco Cicardi
Dipartimento di Scienze Cliniche Luigi Sacco Università di Milano, Milano Italy, Ospedale L, Sacco Milano, Italy
Allergy Asthma Clin Immunol 6:14. 2010..Angioedema prophylaxis is performed using antifibrinolytic agents and attenuated androgens with antifibrinolytic agents providing somewhat better results. Treatment of the associated disease can resolve AAE in some patients...
How do we treat patients with hereditary angioedemaMarco Cicardi
Department of Internal Medicine University of Milan, IRCCS Maggiore Hospital, Milan, Italy
Transfus Apher Sci 29:221-7. 2003..Since that time, 441 such patients have been examined and treated at our department; 403 are still actively followed. Here we present our experience on the treatment of HAE...
Ecallantide for the treatment of acute attacks in hereditary angioedemaMarco Cicardi
University of Milan, Dept of Internal Medicine, Ospedale Luigi Sacco, Via Giovanni Battista Grassi 74, 20157 Milan, Italy
N Engl J Med 363:523-31. 2010..We evaluated ecallantide, a newly developed recombinant plasma kallikrein inhibitor, for the treatment of acute attacks of angioedema...
Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficienciesMarco Cicardi
Department of Internal Medicine, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy
Medicine (Baltimore) 82:274-81. 2003..Antifibrinolytic agents are more effective than attenuated androgens in long-term prophylaxis. Patients with acquired C1-INH deficiency may be resistant to replacement therapy with C1-INH plasma concentrate...
Replacement therapy with C1 esterase inhibitors for hereditary angioedemaM Cicardi
Dipartimento di Scienze Cliniche Luigi Sacco Università di Milano, Ospedale L Sacco, Milano, Italy
Drugs Today (Barc) 46:867-74. 2010..Two plasma-derived C1 inhibitors and a recombinant form, produced in transgenic rabbits, have successfully completed controlled trials that reinforced the evidence of the safety and efficacy of this treatment...
Angioedema due to C1 inhibitor deficiency in 2010Marco Cicardi
Dipartimento di Scienze Cliniche Luigi Sacco, Universita di Milano, Ospedale L Sacco, Milan, Italy
Intern Emerg Med 5:481-6. 2010..Because of these advances, in patients properly diagnosed and treated, the mortality for the disease has dropped close to zero, and the quality of life for patients approaches that of normal subjects...
The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedemaM Cicardi
Dipartimento di Scienze Cliniche L Sacco, Universita di Milano, Ospedale Luigi Sacco, Milano, Italy
Curr Mol Med 10:354-60. 2010..Demonstration that monoclonal components correspond to anti-C1-INH autoantibodies and correlation between course of lymphoma and course of AAE provide strong support to consider the two diseases expression of the same pathologic process...
The deficiency of C1 inhibitor and its treatmentMarco Cicardi
Department of Internal Medicine, University of Milan, San Giuseppe Hospital A Fa R, Milan, Italy
Immunobiology 212:325-31. 2007....
Established and new treatments for hereditary angioedema: An updateMarco Cicardi
Department of Internal Medicine, University of Milan, L Sacco Hospital, Via G B Grassi 74, 20157 Milan, Italy
Mol Immunol 44:3858-61. 2007..Here we review the characteristics of these products and the current situation of the trials...
The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedemaMarco Cicardi
University of Milan, Department of Internal Medicine, Ospedale L Sacco, Via G B Grassi 74, 20157 Milano, Italy
Expert Opin Pharmacother 8:3173-81. 2007..C1-INH is licensed only in a limited number of countries. Clinical trials are ongoing at present to expand registration...
Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatmentMarco Cicardi
Department of Internal Medicine, University of Milan, IRCCS Ospedale Maggiore, Via Pace 9, 20122 Milan, Italy
Arch Intern Med 164:910-3. 2004..We describe 64 consecutive patients with ACE inhibitor-related angioedema, the outcome after discontinuing this treatment, and the safety of using ARBs...
Angioedema due to angiotensin-converting enzyme inhibitorsA Agostoni
Department of Internal Medicine, University of Milan, IRCCS Ospedale, Maggiore, Italy
Immunopharmacology 44:21-5. 1999..These observations indicate that in ACE-inhibitor-induced angioedema, contrary to hereditary angioedema, the reduction of bradykinin catabolic rate plays a predominant role...
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational studyA Zanichelli
Dipartimento di Scienze Cliniche Luigi Sacco, Universita degli Studi di Milano, Milano, Italy
Allergy 67:1074-7. 2012..One peripheral attack responded less quickly than other treated attacks. Five patients reported transient injection site reactions. Icatibant appeared to provide effective symptom relief and was generally well tolerated...
Dental experience and self-perceived dental care needs of patients with angioedemaG Lodi
Dipartimento di Medicina, Chirurgia e Odontoiatria, Universita degli Studi di Milano, Italy
Spec Care Dentist 21:27-31. 2001..More than half (58%) of the group perceived a need for dental care. We conclude that persons with angioedema may experience difficulty in obtaining dental treatment, a common cause of acute attacks...
Bradykinin and the pathophysiology of angioedemaMassimo Cugno
Department of Internal Medicine, University of Milan, IRCCS Maggiore Hospital, Via Pace, 15, 20122 Milan, Italy
Int Immunopharmacol 3:311-7. 2003....
Angioedema without urticaria: a large clinical surveyLorenza C Zingale
Department of Internal Medicine, San Giuseppe Hospital, University of Milan, Milan, Italy
CMAJ 175:1065-70. 2006..Its causes are diverse, and little is known about its pathogenic mechanisms. We report on our 11 years of experience with this condition and propose a classification of patients affected by angioedema unaccompanied by urticaria...
C1 inhibitor: molecular and clinical aspectsMarco Cicardi
Department of Internal Medicine, San Giuseppe Hospital, University of Milan, Milan, Italy
Springer Semin Immunopathol 27:286-98. 2005..We can expect that the introduction of this new product, along with the existing plasma derivative, will renew interest in exploiting C1-INH as a therapeutic agent...
Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferationMassimo Cugno
Department of Internal Medicine, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
Autoimmun Rev 8:156-9. 2008....
C1-inhibitor deficiency and angioedemaA Carugati
Department of Internal Medicine, University of Milan, IRCCS Ospedale Maggiore, Via Pace 9, 20122 Milan, Italy
Mol Immunol 38:161-73. 2001..A special remark to this treatment should be made for autoantibody-mediated AAE where very high doses can be needed depending on the rate of C1-Inh consumption...
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiencyM Cugno
Department of Internal Medicine, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
Allergy 64:254-7. 2009..Although cutaneous swelling is evident, abdominal angioedema is still a diagnostic challenge and attacks can mimic surgical emergencies. There is currently no laboratory marker for identifying angioedema attacks...
Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patientsA Zanichelli
Dipartimento di Scienze Cliniche L Sacco, Universita degli Studi di Milano, Ospedale Luigi Sacco, Milan, Italy
Allergy 66:192-6. 2011..Hereditary angioedema (HAE) due to the deficiency of C1 inhibitor (C1-INH) causes chronically recurrent cutaneous, abdominal and laryngeal angioedema that are disabling and potentially life-threatening...
Drug-induced angioedema without urticariaA Agostoni
Department of Internal Medicine, IRCCS Milan Maggiore Hospital, University of Milan, Italy
Drug Saf 24:599-606. 2001..If the acute airway obstruction leads to life-threatening respiratory compromise an emergency cricothyroidotomy must be performed...
Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with itLaura Beltrami
San Giuseppe Hospital-AFaR, University of Milan, Department of Internal Medicine, Via San Vittore 12, 20123, Milan, Italy
Expert Opin Drug Saf 5:643-9. 2006..In this review, the authors analyse the pathogenetic mechanism, the clinical presentation, the management and future perspectives of research on this condition...
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional managementLorenza Chiara Zingale
Department of Internal Medicine, San Giuseppe Hospital-AFaR (Ospedale San Giuseppe, University of Milan, Via San Vittore 12, 20123 Milano, Italy
Immunol Allergy Clin North Am 26:669-90. 2006..Moreover, the authors give an overview of the outcome of the disease and the different therapies proposed to cure it...
Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with DanazolEmanuela Pappalardo
Department of Internal Medicine, IRCCS Maggiore Hospital, University of Milan, Via Pace 9, Milan 20122, Italy
Immunol Lett 86:271-6. 2003..Our data demonstrate that minimal effective doses of Danazol increase the expression of C1-INH mRNA in PBMC of HAE patients even in the absence of a significant increase of C1-INH plasma levels...
A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-->Leu)D Frangi
Clinica Medica V, Universita di Milano, Ospedale S Paolo, Italy
FEBS Lett 301:34-6. 1992..The mutation was defined at the level of the protein (by sequence analysis of the Pseudomonas aeruginosa elastase-derived reactive center peptide), and the mRNA (CGC-->CTC) (by sequence analysis of PCR-amplified DNA)...
Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiencyM van Geffen
Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Clin Exp Immunol 167:472-8. 2012....
Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathwayL Bergamaschini
Department of Internal Medicine, Maggiore Hospital IRCCS, University of Milan, Milan, Italy
Clin Exp Immunol 116:220-4. 1999..The results of this study indicate that C4BP is consumed in vivo during acute, and possibly during chronic activation of the C' classical pathway, and that this protein, after interaction with C4b, not longer circulates in plasma...
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyondAngelo Agostoni
University of Milan, Italy
J Allergy Clin Immunol 114:S51-131. 2004..This supplement seeks to raise awareness and aid diagnosis of HAE, optimize treatment for all patients, and provide a platform for further research in this rare, partially understood disorder...
Successful resolution of bowel obstruction in a patient with hereditary angioedemaLorenza C Zingale
Department of Clinical Science L Sacco, University of Milan, Ospedale L Sacco, Milan, Italy
Eur J Gastroenterol Hepatol 20:583-7. 2008..Furthermore, it illustrates the usefulness of videos obtained from capsule endoscopy in identifying the presence of bowel occlusion and demonstrating its subsequent rapid resolution upon administration of DX-88...
C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progressMassimo Cugno
Department of Internal Medicine, University of Milan, Mangiagalli e Regina Elena, Milan 20122, Italy
Trends Mol Med 15:69-78. 2009..Here, we review the molecular mechanisms underlying angioedema due to C1-inhibitor deficiency and clinical progress using molecular-targeted interventions...
Research on complement: old issues revisited and a novel sphere of influenceLiliana Clemenza
Department of Biopathology and Biomedical Methodologies, University of Palermo, Italy, Corso Tukory 211, Italy
Trends Immunol 24:292-6. 2003..We cover papers selected from studies presented at the XIX International Complement Workshop, held in Palermo in September 2002, and published within the past six months...
Recent advances in the use of C1 inhibitor as a therapeutic agentLuigi Bergamaschini
Department of Internal Medicine, University of Milan, IRCCS Ospedale Maggiore, Via Pace 9, 20122 Milan, Italy
Mol Immunol 40:155-8. 2003
C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCREmanuela Pappalardo
Department of Internal Medicine, University of Milan, Ospedale S Giuseppe, 20123 Milan, Italy
J Allergy Clin Immunol 114:638-44. 2004..Most patients have antigenic and functional deficiency (type I HAE), and 15% have reduced C1-INH function but normal to increased antigen because of the presence of a dysfunctional protein (type II HAE)...
Bradykinin-mediated angioedemaJuerg Nussberger
N Engl J Med 347:621-2. 2002
Lymphoproliferative disease and acquired C1 inhibitor deficiencyRoberto Castelli
Haematologica 92:716-8. 2007..Our series suggest that different forms of B cell disorders coexist and/or evolve into each other in acquired angioedema...
Mechanisms of C1-inhibitor deficiencyEmanuela Pappalardo
Immunobiology 205:542-51. 2002..Such conditions, as extensively investigated in sepsis, are of great relevance because they open the possibility of using C1-Inh as therapeutic agent in several different diseases...
Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedemaBeata Visy
Madarász Street Hospital of the Heim Pál Pediatric Hospital, Budapest, Hungary
Helicobacter 12:251-7. 2007..The present study aimed to reinvestigate the relationship between H. pylori infection and the attack rate in the framework of an international collaborative study...
Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary AngioedemaTom Bowen
Department of Medicine and Paeditrics, University of Calgary, Calgary, Alberta T2N 2T8, Canada
J Allergy Clin Immunol 114:629-37. 2004..Hopefully evidence to support approaches to the management of HAE will approach the level of meta-analysis of randomized controlled trials in the near future...
Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendationsIneke G A Wagenaar-Bos
Department of Immunopathology, University of Amsterdam, Amsterdam, The Netherlands
J Immunol Methods 338:14-20. 2008..It can be concluded that the diagnosis of fC1-Inh deficiency was made correctly in most cases in this survey. We can recommend the chromogenic assay for the determination of fC1-Inh, while the complex ELISA needs further investigation...
